Transcriptional profile of primary astrocytes expressing ALS‐linked mutant SOD1

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Neuroscience Research

• Publication date

  2008-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jnr.21797PMID 18683239PMCID PMC4048747
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis

  2008cited by this paper
• Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

  2007cited by this paper
• Decorin Promotes Plasminogen/Plasmin Expression within Acute Spinal Cord Injuries and by Adult Microglia In Vitro

  2006cited by this paper
• Identification of Astrocyte-expressed Factors That Modulate Neural Stem/Progenitor Cell Differentiation

  2006cited by this paper
• Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTR‐dependent motor neuron apoptosis

  2006cited by this paper
• ALADINI482S causes selective failure of nuclear protein import and hypersensitivity to oxidative stress in triple A syndrome

  2006cited by this paper
• The Role of RNA and RNA Processing in Neurodegeneration

  2005cited by this paper
• Fibroblast Growth Factor-1 Induces Heme Oxygenase-1 via Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) in Spinal Cord Astrocytes CONSEQUENCES FOR MOTOR NEURON SURVIVAL*

  2005cited by this paper
• Mitochondrial dysfunction and its role in motor neuron degeneration in ALS.

  2005cited by this paper
• Astrocyte activation by fibroblast growth factor‐1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosis

  2005cited by this paper
• Fibroblast Growth Factor-1 Induces Heme Oxygenase-1 via Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) in Spinal Cord Astrocytes

  2005cited by this paper
• Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis

  2005cited by this paper
• Decorin, a Novel Player in the Insulin-like Growth Factor System*

  2005cited by this paper
• Astrocytes, from brain glue to communication elements: the revolution continues

  2005influential reference
• Neuronal migration and the role of reelin during early development of the cerebral cortex

  2004cited by this paper
• Unraveling the mechanisms involved in motor neuron degeneration in ALS.

  2004cited by this paper
• LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription.

  2004cited by this paper
• Spinal cord molecular profiling provides a better understanding of amyotrophic lateral sclerosis pathogenesis.

  2004cited by this paper
• Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis

  2004cited by this paper
• Benefit of valproic acid in suppressing disease progression of ALS model mice

  2004cited by this paper
• Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries

  2004cited by this paper
• Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter.

  2004cited by this paper
• A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis.

  2004cited by this paper
• Free insulin-like growth factor (IGF)-I and IGF binding proteins 2, 5, and 6 in spinal motor neurons in amyotrophic lateral sclerosis.

  2003influential reference
• Expression and localization of cyclooxygenase‐1 and ‐2 in human sporadic amyotrophic lateral sclerosis

  2003cited by this paper
• A neurotoxic peripherin splice variant in a mouse model of ALS

  2003cited by this paper
• Microarray Analysis

  2003cited by this paper
• Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model

  2003cited by this paper
• Immunohistochemical study on the distribution of insulin-like growth factor I (IGF-I) receptor in the central nervous system of SOD1(G93A) mutant transgenic mice.

  2003cited by this paper
• Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice

  2003cited by this paper
• Differential expression of inflammation‐ and apoptosis‐related genes in spinal cords of a mutant SOD1 transgenic mouse 
model of familial amyotrophic lateral sclerosis

  2002cited by this paper
• Accumulation of SOD1 Mutants in Postnatal Motoneurons Does Not Cause Motoneuron Pathology or Motoneuron Disease

  2002cited by this paper
• Decorin Binds to a Narrow Region of the Epidermal Growth Factor (EGF) Receptor, Partially Overlapping but Distinct from the EGF-binding Epitope*

  2002cited by this paper
• Peroxynitrite triggers a phenotypic transformation in spinal cord astrocytes that induces motor neuron apoptosis

  2002cited by this paper
• Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)

  2002influential reference
• Acidic fibroblast growth factor (FGF-1) in the anterior horn cells of ALS and control cases

  2001cited by this paper
• Glial cells of the spinal cord and subcortical white matter up-regulate neuronal nitric oxide synthase in sporadic amyotrophic lateral sclerosis.

  2001cited by this paper
• Rats Expressing Human Cytosolic Copper–Zinc Superoxide Dismutase Transgenes with Amyotrophic Lateral Sclerosis: Associated Mutations Develop Motor Neuron Disease

  2001cited by this paper
• Disease mechanisms revealed by transcription profiling in SOD1‐G93A transgenic mouse spinal cord

  2001cited by this paper
• Superoxide dismutase and the death of motoneurons in ALS.

  2001cited by this paper
• Neuron-Specific Expression of Mutant Superoxide Dismutase 1 in Transgenic Mice Does Not Lead to Motor Impairment

  2001cited by this paper
• From charcot to lou gehrig: deciphering selective motor neuron death in als

  2001cited by this paper
• Restricted Expression of G86R Cu/Zn Superoxide Dismutase in Astrocytes Results in Astrocytosis But Does Not Cause Motoneuron Degeneration

  2000cited by this paper
• iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis.

  2000cited by this paper
• Inducible Nitric Oxide Synthase Up‐Regulation in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis

  1999cited by this paper
• Decorin attenuates gliotic scar formation in the rat cerebral hemisphere.

  1999cited by this paper
• S-100beta protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis.

  1999cited by this paper
• Isolation of a Mammalian Homologue of a Fission Yeast Differentiation Regulator

  1999influential reference
• S-100β protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis

  1999cited by this paper
• Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis.

  1998cited by this paper
• Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.

  1998cited by this paper
• A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis

  1998cited by this paper
• Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS

  1998cited by this paper
• The ephrins and Eph receptors in neural development.

  1998cited by this paper
• A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group.

  1998cited by this paper
• Reactive astrocytes: cellular and molecular cues to biological function.

  1997cited by this paper
• ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

  1997cited by this paper
• Effect of recombinant human insulin-like growth factor-I on progression of ALS

  1997cited by this paper
• Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group.

  1997cited by this paper
• Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis.

  1997cited by this paper
• Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury

  1996cited by this paper
• Neuropathology of ALS

  1996cited by this paper
• Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients.

  1996cited by this paper
• Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins.

  1995cited by this paper
• Differential expression of the small chondroitin/dermatan sulfate proteoglycans decorin and biglycan after injury of the adult rat brain.

  1995cited by this paper
• Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

  1994cited by this paper
• Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis

  1994cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

  1993cited by this paper
• Neurite promoting activity of insulin, insulin-like growth factor I and nerve growth factor on spinal motoneurons is astrocyte dependent.

  1993cited by this paper
• Effects of astrocytes, insulin and insulin-like growth factor I on the survival of motoneurons in vitro.

  1992cited by this paper
• Reactive Astrogliosis is Widespread in the Subcortical White Matter of Amyotrophic Lateral Sclerosis Brain

  1991cited by this paper
• Negative regulation of transforming growth factor-β by the proteoglycan decorin

  1990cited by this paper
• Negative regulation of transforming growth factor-beta by the proteoglycan decorin.

  1990cited by this paper

• Decorin Attenuates Epileptogenesis and Modulates Hippocampal Synaptic Plasticity via the mTOR Signalling Pathway

  2026cites this paper
• Heavy Metals Toxicity: Mechanism, Health Effects, and Therapeutic Interventions

  2025cites this paper
• Exploring the properties and potential of the neural extracellular matrix for next-generation regenerative therapies.

  2024cites this paper
• Reactive astrocytes in ALS display diminished intron retention

  2021cites this paper
• PET imaging of reactive astrocytes in neurological disorders

  2021cites this paper
• Copper Dyshomeostasis in Neurodegenerative Diseases—Therapeutic Implications

  2020cites this paper
• Neurovascular Inflammaging in Health and Disease

  2020cites this paper
• Examining the relationship between astrocyte dysfunction and neurodegeneration in ALS using hiPSCs.

  2019cites this paper
• Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis.

  2018influential citation
• Phenotypic heterogeneity of astrocytes in motor neuron disease

  2018cites this paper
• Transcriptomics in amyotrophic lateral sclerosis.

  2018cites this paper
• SOD1 Mutations Causing Familial Amyotrophic Lateral Sclerosis Induce Toxicity in Astrocytes: Evidence for Bystander Effects in a Continuum of Astrogliosis

  2017cites this paper
• Necroptosis in amyotrophic lateral sclerosis and other neurological disorders.

  2017cites this paper
• Microambiente celular neurodegenerativo en un modelo de Esclerosis Lateral Amiotrófica

  2017cites this paper
• Could astrocytes be the primary target of an offending agent causing the primary degenerative diseases of the human central nervous system? A hypothesis.

  2015cites this paper
• NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients

  2015influential citation
• Dysregulated expression of death, stress and mitochondrion related genes in the sciatic nerve of presymptomatic SOD1G93A mouse model of Amyotrophic Lateral Sclerosis

  2015cites this paper
• Deregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1G93A Amyotrophic Lateral Sclerosis mouse model

  2014cites this paper
• Mutant SOD1-expressing astrocytes release toxic factors that trigger motoneuron death by inducing hyperexcitability.

  2013cites this paper
• Unraveling the molecular mechanism underlying ALS-linked astrocyte toxicity for motor neurons

  2013cites this paper
• Meta-analysis of gene expression profiling in amyotrophic lateral sclerosis: A comparison between transgenic mouse models and human patients

  2013cites this paper
• Investigating cell death mechanisms in amyotrophic lateral sclerosis using transcriptomics

  2013cites this paper
• Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy

  2013cites this paper
• Melanocortins as innovative drugs for ischemic diseases and neurodegenerative disorders: established data and perspectives.

  2013cites this paper
• Transcriptome Profiling Following Neuronal and Glial Expression of ALS-Linked SOD1 in Drosophila

  2013cites this paper
• Ablation of Keratan Sulfate Accelerates Early Phase Pathogenesis of ALS

  2013cites this paper
• Altered astrocytic response to activation in SOD1G93A mice and its implications on amyotrophic lateral sclerosis pathogenesis

  2013cites this paper
• Dissecting neuronal dysfunction and microglia/motoneurons cross-talk in ALS: an immunofluorescence directed study

  2013influential citation
• Amyotrophic lateral sclerosis: new insights into underlying molecular mechanisms and opportunities for therapeutic intervention.

  2012cites this paper
• Insights Arising from Gene Expression Profiling in Amyotrophic Lateral Sclerosis

  2012cites this paper
• Impairments to the GH-IGF-I axis in hSOD1G93A mice give insight into possible mechanisms of GH dysregulation in patients with amyotrophic lateral sclerosis.

  2012cites this paper
• Altered Gene Expression, Mitochondrial Damage and Oxidative Stress: Converging Routes in Motor Neuron Degeneration

  2012cites this paper
• Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters

  2012cites this paper
• The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis

  2012cites this paper
• Upregulation of the E3 ligase NEDD4-1 by Oxidative Stress Degrades IGF-1 Receptor Protein in Neurodegeneration

  2012cites this paper
• The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases.

  2012cites this paper
• 2 Insights Arising from Gene Expression Profiling in Amyotrophic Lateral Sclerosis

  2012cites this paper
• Mechanizmy patogenetyczne stwardnienia bocznego zanikowego

  2012cites this paper
• Can Transcriptomics Cut the Gordian Knot of Amyotrophic Lateral Sclerosis?

  2011cites this paper
• Inflammation in the early stages of neurodegenerative pathology.

  2011cites this paper
• Neonatal Astrocyte Damage Is Sufficient to Trigger Progressive Striatal Degeneration in a Rat Model of Glutaric Acidemia-I

  2011cites this paper
• Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology

  2011cites this paper
• High angular resolution diffusion-weighted magnetic resonance imaging: Adaptive smoothing and applications

  2010cites this paper
• Mechanisms underlying inflammation in neurodegeneration.

  2010cites this paper
• Astrogliosis in amyotrophic lateral sclerosis: Role and therapeutic potential of astrocytes

  2010influential citation
• Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis.

  2010cites this paper
• Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments.

  2010cites this paper
• Differential expression and alternative splicing of genes in lumbar spinal cord of an amyotrophic lateral sclerosis mouse model.

  2010cites this paper
• The Human G93A-Superoxide Dismutase-1 Mutation, Mitochondrial Glutathione and Apoptotic Cell Death

  2009cites this paper
• The importance of molecular histology to study glial influence on neurodegenerative disorders. Focus on recent developed single cell laser microdissection

  2009cites this paper
• Astrocyte function and role in motor neuron disease: A future therapeutic target?

  2009cites this paper
• Astrocyte Pathology and the Absence of Non-cell Autonomy in an Induced Pluripotent Stem Cell Model of Tdp-43 Proteinopathy

  year unknowncites this paper
• Astrocyte Pathology and the Absence of Non-cell Autonomy in an Induced Pluripotent Stem Cell Model of Tdp-43 Proteinopathy

  year unknowncites this paper